Compare MGPI & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MGPI | TRDA |
|---|---|---|
| Founded | 1941 | 2016 |
| Country | United States | United States |
| Employees | 267 | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 323.8M | 275.3M |
| IPO Year | 1994 | 2021 |
| Metric | MGPI | TRDA |
|---|---|---|
| Price | $17.05 | $4.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $26.40 | $19.00 |
| AVG Volume (30 Days) | 246.1K | ★ 369.7K |
| Earning Date | 10-28-2026 | 11-09-2026 |
| Dividend Yield | ★ 2.87% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $19,782,000.00 | ★ $25,421,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.95 | $87.87 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.42 | $4.11 |
| 52 Week High | $26.62 | $16.45 |
| Indicator | MGPI | TRDA |
|---|---|---|
| Relative Strength Index (RSI) | 68.50 | 37.97 |
| Support Level | $16.02 | $4.11 |
| Resistance Level | $18.44 | $7.89 |
| Average True Range (ATR) | 0.69 | 0.49 |
| MACD | 0.29 | 0.02 |
| Stochastic Oscillator | 92.71 | 17.13 |
MGP Ingredients Inc is a producer and supplier of distilled spirits, specialty wheat protein, and starch food ingredients based in the United States. It operates in three reportable segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Maximum revenue is generated from the Branded Spirits segment, which consists of a portfolio of brands that it produces through its distilleries and bottling facilities and sells to distributors or to state governments that directly control the sale of alcohol. MGP's branded spirits include various brands across numerous categories and price tiers, such as Penelope Bourbon, Yellowstone Bourbon, Minor Case Straight Rye Whiskey, Brady's Irish Cream, Exotico Tequila, Arrow Cordials, Canada House Canadian Whisky, Lady Bligh Rum, etc.
Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.